![PathogenDX](https://i0.wp.com/specials-images.forbesimg.com/imageserve/5d9259928b5ffa000655735c/960x0.jpg?w=580&ssl=1)
PHOTO COURTESY; PATHOGENDX
PathogenDx, Inc., an innovator in DNA-based pathogen testing technology for cannabis, hemp, agriculture and food safety industries, announced Monday it has secured $7.5 million in Series B funding. The company was able to close this round of funding in just under three months.